SYDNIE THESSING: Open Payments
NPI 1780191015 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 17 payments from 9 companies in 2025. Trend: 2023 $665 · 2024 $523 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $81 |
| PFIZER INC. | 3 | $51 |
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Kestra Medical Technology Services, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Amgen Inc. | 1 | $14 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: VERQUVO, ELIQUIS, LEQVIO, Assure WCD, FARXIGA, REPATHA, Kerendia, VOQUEZNA.
Industry payments across AR — which companies pay providers there.
